Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is proud to announce the launch of its D
The Nobel Prize in Physiology or Medicine awarded
This year, the Hamburg based life sciences company
Alembic Pharmaceuticals Ltd., t
Since it’s an ingredient in so many foods, you h
Dear Readers,Welcome to the latest issue of Microb
Dr. Hemant R. Jadhav, a BITS Pilani professor, spends his days sketching tiny drug-like shapes on a computer screen and nights watching them grow into real compounds. His work targets cancer, HIV, Alzheimer’s, and diabetes—blending molecular design with hands-on testing to yield future-ready therapies.
At the core of his research are histone demethylases—epigenetic gatekeepers that control disease expression like a lock-and-key system. By combining in-silico predictions with experimental pharmacology, Dr. Jadhav is accelerating the drug discovery timeline.
Despite challenges in solubility, selectivity, and scalability, his multidisciplinary approach paves the way for smarter, more effective treatments.
Come prepared to think differently. This isn’t your usual lecture. Dr. Jadhav’s sharp insights make this a can’t-miss session—especially if you’re invested in the future of precision medicine.
